Results 71 to 80 of about 1,807,693 (260)

miR‐671‐5p repressed progression of papillary thyroid carcinoma via TRIM14

open access: yesKaohsiung Journal of Medical Sciences, 2021
The pivotal role of dysregulated miRNAs in development of papillary thyroid carcinoma has been emphasized in recent research. miR‐671‐5p was previously documented to function as a tumor suppressor.
Wan‐Ju Wang   +4 more
doaj   +1 more source

IGF-I influences everolimus activity in medullary thyroid carcinoma [PDF]

open access: yes, 2015
Context: Medullary thyroid carcinoma (MTC) is a rare tumor originating from thyroid parafollicular C cells. It has been previously demonstrated that insulin-like growth factor I (IGF-I) protects MTC from the effects of antiproliferative drugs. Everolimus,
degli Uberti, Ettore C.   +9 more
core   +1 more source

Uncovering the connection between obesity and thyroid cancer: the therapeutic potential of adiponectin receptor agonist in the AdipoR2-ULK axis

open access: yesCell Death and Disease
Adiponectin, a unique adipose-derived factor, is significantly downregulated in obesity, making it a crucial target for tumor-related metabolic research.
Changlin Li   +5 more
doaj   +1 more source

Critically evaluated key points on hereditary medullary thyroid carcinoma

open access: yesFrontiers in Endocrinology
Medullary thyroid carcinoma (MTC) accounts for only 3% of all thyroid carcinomas: 75% as sporadic MTC (sMTC) and 25% as hereditary MTC (hMTC) in the context of multiple endocrine neoplasia type 2 (MEN2).
Daqi Zhang   +8 more
doaj   +1 more source

Functional characterization of human thyroid tissue with immunohistochemistry [PDF]

open access: yes, 2007
Immunohistochemistry provides insights in the expression of functional proteins and of their localization in normal thyroid tissue and in thyroid diseases.
Bernard, Caillou   +6 more
core   +1 more source

Zn(II)-curc targets p53 in thyroid cancer cells [PDF]

open access: yes, 2015
P53 mutation is a common event in many cancers, including thyroid carcinoma. Defective p53 activity promotes cancer resistance to therapies and a more malignant phenotype, acquiring oncogenic functions.
Crispini, Alessandra   +3 more
core   +2 more sources

Analysis of thyroid carcinomas with immunohistochemical panel application: retrospectively study of 52 cases [PDF]

open access: yesĶazaķstannyṇ Klinikalyķ Medicinasy, 2019
Aim: The aim of this study was to share our cases of thyroid carcinoma with the literature and to emphasize the importance of evaluation with an immunohistochemical panel in cases with difficulty in the differential diagnosis.
Mecdi Gurhan Balci, Mahir Tayfur
doaj   +1 more source

The role of peroxiredoxins in cancer [PDF]

open access: yes, 2017
Peroxiredoxins (PRDXs) are a ubiquitously expressed family of small (22-27 kDa) non-seleno peroxidases that catalyze the peroxide reduction of H2O2, organic hydroperoxides and peroxynitrite.
CAPALBO, CARLO   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy